The Ensign Group, Inc. (ENSG) 股票分析

公司概述

The Ensign Group, Inc. operates within the healthcare sector, specifically serving the medical care facilities industry by providing skilled nursing, senior living, and rehabilitative services through its Skilled Services and Standard Bearer segments. These services are designed to support patients with chronic conditions and prolonged illnesses through both short-term and long-term nursing care. The company demonstrates significant scale with a total market capitalization of $11.77 billion and an annual revenue of $5.06 billion based on trailing twelve-month figures. Supporting this operational footprint, the organization employs approximately 46,000 individuals across its various facilities. These valuation and revenue metrics indicate that The Ensign Group, Inc. is a substantial entity within the healthcare infrastructure, commanding a significant market presence that reflects its extensive service delivery network.

财务健康

The company reported a revenue of $5.06 billion for the trailing twelve months, generating a net income of $343.97 million and an EBITDA of $528.67 million. The substantial gap between the $5.06 billion revenue and the $343.97 million net income highlights a cost structure where operating expenses, including cost of goods sold and overhead, consume a significant portion of top-line sales before reaching the bottom line. Free cash flow stands at $281.25 million, providing the firm with essential financial flexibility to fund operations, maintain facilities, or service debt obligations without relying solely on external financing. Regarding profitability efficiency, the gross margin is 16.3%, the operating margin is 9.1%, and the profit margin is 6.8%, indicating that for every dollar of revenue, a small fraction remains as net profit after all costs are deducted. The balance sheet shows a cash position of $572.39 million against total debt of $2.21 billion, resulting in a debt-to-equity ratio of 98.70, which suggests a leveraged capital structure where debt usage is nearly equal to equity. Despite the leverage, the current ratio of 1.42 indicates adequate short-term liquidity, as the company holds sufficient current assets to cover its current liabilities. Return on equity is 16.9% while return on assets is 5.2%, revealing that management generates a high return relative to shareholder equity but a lower return relative to the total asset base utilized.

估值评估

Valuation metrics for the stock include a trailing P/E ratio of 34.45 and a forward P/E of 24.47. The notable difference between the trailing and forward P/E ratios implies that the market expects earnings to increase significantly in the future, compressing the multiple from the current historical average to a lower forward projection. The price-to-book ratio is 5.21, indicating that the market values the company at more than five times its book value, suggesting a premium assigned to its intangible assets or growth prospects. Alternative valuation measures such as the price-to-sales ratio of 2.33 and an EV/EBITDA of 25.09 provide additional context, showing that the stock trades at a premium relative to both sales and earnings before interest, taxes, depreciation, and amortization. In terms of trading range, the 52-week high is $218.00 and the 52-week low is $118.73, with the current trading price reflecting recent market volatility within this specific band. The beta value of 0.82 indicates that the stock price volatility is lower than the broader market, suggesting a defensive characteristic often found in healthcare utilities and services.

Growth & Income

The company has demonstrated robust expansion with a revenue growth of 20.2% year-over-year and an earnings growth of 18.4% year-over-year. Earnings are growing slightly slower than revenue, which implies that the company is maintaining its profit margins while scaling its operations, rather than facing immediate margin compression. Regarding income distribution, the dividend yield is 0.1% with a payout ratio of 4.3%, reflecting a minimal distribution of earnings to shareholders. This low payout ratio indicates that the company retains the vast majority of its earnings to reinvest into business growth, facility expansion, or debt reduction rather than prioritizing dividend payments. The overall growth and income profile is characterized by high double-digit revenue expansion paired with a conservative dividend policy that prioritizes capital allocation for internal development over shareholder cash returns.